Abbott

The single-chamber ventricular leadless pacemaker is made for the treatment of patients in India with slow heart rhythms

Transcatheter tricuspid valve repair sees swift market growth as Abbott’s Triclip captures majority share

Event explored behavioural insights and tech innovations for improving treatment adherence

Survey reveals that infectious disease experts see the need to address gaps in surveillance programs to identify emerging…

Medtronic's new collaboration with Abbott aims to enhance its diabetes care offerings by integrating advanced glucose monitoring…

Abbott's AVEIR DR dual chamber leadless pacemaker disrupts the market, capturing significant share from Medtronic and setting new…

The Blue Shed facility in Delhi will offer holistic care to people who are vulnerable to HIV, hepatitis, and other infectious…

The global dual chamber leadless pacemaker market is poised to grow at a CAGR of 8.95 per cent from $185.9 million in 2023 to $438…

This coronary stent enables physicians to access and unblock difficult-to-treat blockages

This automation solution has been installed in Ahmedabad, Bengaluru, Chennai and Srinagar